Trial Profile
Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 05 Jun 2008 New trial record.